Murae Organisor [MURAE] vs Medplus Health [MEDPLUS] Detailed Stock Comparison
Murae Organisor
BSE
Loading...
Medplus Health
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Murae Organisor wins in 6 metrics, Medplus Health wins in 12 metrics, with 0 ties. Medplus Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Murae Organisor | Medplus Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 14.25 | 56.08 | Murae Organisor |
| Price-to-Book Ratio | 0.57 | 5.70 | Murae Organisor |
| Debt-to-Equity Ratio | 102.06 | 64.36 | Medplus Health |
| PEG Ratio | N/A | 0.29 | N/A |
| EV/EBITDA | 28.47 | 30.73 | Murae Organisor |
| Profit Margin (TTM) | 0.88% | 2.88% | Medplus Health |
| Operating Margin (TTM) | 0.75% | 4.22% | Medplus Health |
| EBITDA Margin (TTM) | 0.75% | 4.22% | Medplus Health |
| Return on Equity | 5.69% | 8.64% | Medplus Health |
| Return on Assets (TTM) | 1.63% | 4.47% | Medplus Health |
| Free Cash Flow (TTM) | $-3.23B | $4.81B | Medplus Health |
| 1-Year Return | -4.84% | 30.48% | Medplus Health |
| Price-to-Sales Ratio (TTM) | 0.14 | 1.62 | Murae Organisor |
| Enterprise Value | $2.86B | $107.10B | Medplus Health |
| EV/Revenue Ratio | 0.33 | 1.73 | Murae Organisor |
| Gross Profit Margin (TTM) | 0.84% | 26.12% | Medplus Health |
| Revenue per Share (TTM) | $4 | $518 | Medplus Health |
| Earnings per Share (Diluted) | $0.04 | $14.89 | Medplus Health |
| Beta (Stock Volatility) | -1.06 | 0.69 | Murae Organisor |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Murae Organisor vs Medplus Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Murae Organisor | 3.51% | -8.06% | -29.63% | -10.94% | -25.00% | -41.84% |
| Medplus Health | -0.88% | 1.81% | -8.60% | -7.09% | 14.63% | -2.35% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Murae Organisor | -4.84% | -48.70% | -82.23% | -62.18% | -62.18% | -62.18% |
| Medplus Health | 30.48% | 10.93% | -23.00% | -23.00% | -23.00% | -23.00% |
Performance & Financial Health Analysis: Murae Organisor vs Medplus Health
| Metric | MURAE | MEDPLUS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.17B | ₹100.03B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 3,775,189 | 374,485 |
| 90 Day Avg. Volume | 47,140,100 | 212,400 |
| Last Close | ₹0.59 | ₹821.25 |
| 52 Week Range | ₹0.48 - ₹1.27 | ₹616.00 - ₹1,045.30 |
| % from 52W High | -53.48% | -21.43% |
| All-Time High | ₹13.20 (Sep 20, 2021) | ₹1,343.00 (Jan 17, 2022) |
| % from All-Time High | -95.53% | -38.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.83% | 0.04% |
| Quarterly Earnings Growth | 1.44% | 1.95% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.03% |
| Operating Margin (TTM) | 0.01% | 0.04% |
| Return on Equity (TTM) | 0.06% | 0.09% |
| Debt to Equity (MRQ) | 102.06 | 64.36 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹0.99 | ₹146.47 |
| Cash per Share (MRQ) | ₹0.22 | ₹30.67 |
| Operating Cash Flow (TTM) | ₹-3,229,690,112 | ₹3.31B |
| Levered Free Cash Flow (TTM) | ₹-3,242,445,824 | ₹1.50B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Murae Organisor vs Medplus Health
| Metric | MURAE | MEDPLUS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 14.25 | 56.08 |
| Forward P/E | N/A | 55.22 |
| PEG Ratio | N/A | 0.29 |
| Price to Sales (TTM) | 0.14 | 1.62 |
| Price to Book (MRQ) | 0.57 | 5.70 |
| Market Capitalization | ||
| Market Capitalization | ₹1.17B | ₹100.03B |
| Enterprise Value | ₹2.86B | ₹107.10B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.33 | 1.73 |
| Enterprise to EBITDA | 28.47 | 30.73 |
| Risk & Other Metrics | ||
| Beta | -1.06 | 0.69 |
| Book Value per Share (MRQ) | ₹0.99 | ₹146.47 |
Financial Statements Comparison: Murae Organisor vs Medplus Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MURAE | MEDPLUS |
|---|---|---|
| Revenue/Sales | ₹5.16B | ₹15.43B |
| Cost of Goods Sold | ₹5.11B | ₹11.40B |
| Gross Profit | ₹43.38M | ₹4.03B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹38.93M | ₹651.12M |
| EBITDA | ₹38.94M | ₹1.46B |
| Pre-Tax Income | ₹38.93M | ₹527.66M |
| Income Tax | ₹10.39M | ₹104.23M |
| Net Income (Profit) | ₹28.53M | ₹423.43M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MURAE | MEDPLUS |
|---|---|---|
| Cash & Equivalents | ₹465.71M | ₹860.52M |
| Total Current Assets | ₹6.52B | ₹18.44B |
| Total Current Liabilities | ₹2.31B | ₹5.77B |
| Long-Term Debt | ₹2.13B | ₹10.08B |
| Total Shareholders Equity | ₹2.08B | ₹17.40B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | N/A | ₹12.49B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MURAE | MEDPLUS |
|---|---|---|
| Operating Cash Flow | ₹54.94M | N/A |
| Capital Expenditures | ₹-3.18M | N/A |
| Free Cash Flow | ₹-14.79M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | ₹-1.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MURAE | MEDPLUS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 3,775,189 | 374,485 |
| Average Daily Volume (90 Day) | 47,140,100 | 212,400 |
| Shares Outstanding | 929.48M | 119.64M |
| Float Shares | 305.45M | 69.21M |
| % Held by Insiders | 0.67% | 0.42% |
| % Held by Institutions | 0.00% | 0.34% |
Dividend Analysis & Yield Comparison: Murae Organisor vs Medplus Health
| Metric | MURAE | MEDPLUS |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |